Cargando…

N6-Methyladenosine (m(6)A)-Related lncRNAs Are Potential Signatures for Predicting Prognosis and Immune Response in Lung Squamous Cell Carcinoma

BACKGROUND: Despite increasing understanding of m(6)A-related lncRNAs in lung cancer, the role of m(6)A-related lncRNAs in the prognosis and treatment of lung squamous cell carcinoma is poorly understood to date. Thus, the current study aims to elucidate its role and build a model to predict the pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yang, Guan, Xuhui, Wang, Shuncong, Sun, Huanhuan, Ma, Haiqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462982/ https://www.ncbi.nlm.nih.gov/pubmed/36090906 http://dx.doi.org/10.1155/2022/5240611

Ejemplares similares

The functions of N6-methyladenosine modification in lncRNAs
por: He, Rong-Zhang, et al.
Publicado: (2020)

Identification of N6-Methyladenosine-Related lncRNAs as a Prognostic Signature in Glioma
por: Chen, Yujia, et al.
Publicado: (2022)

Identification and validation of N6-methyladenosine (m6A)-related lncRNAs signature for predicting the prognosis of laryngeal carcinoma, especially for smoking patients
por: Chen, Yuqing, et al.
Publicado: (2023)

The Role of N6-Methyladenosine-Associated lncRNAs in the Immune Microenvironment and Prognosis of Colorectal Cancer
por: Yuan, Congfei, et al.
Publicado: (2022)

Comprehensive analysis of lncRNAs N(6)-methyladenosine modification in colorectal cancer
por: Zuo, Luo, et al.
Publicado: (2021)

N6-Methyladenosine-Related lncRNAs Are Anticipated Biomarkers for Sarcoma Patients
por: Zhang, Xiaohe, et al.
Publicado: (2022)

Establishment of Prognostic Signatures of N6-Methyladenosine-Related lncRNAs and Their Potential Functions in Hepatocellular Carcinoma Patients
por: Wu, Xianbin, et al.
Publicado: (2022)

N6-methyladenosine (m6A)-connected lncRNAs are linked to survival and immune infiltration in glioma patients
por: Wu, Wei Jun, et al.
Publicado: (2023)

N6-methyladenosine-related lncRNAs is a potential marker for predicting prognosis and immunotherapy in ovarian cancer
por: Nie, Xin, et al.
Publicado: (2022)

N6-methyladenosine-related lncRNAs in combination with computational histopathology and radiomics predict the prognosis of bladder cancer
por: Huang, Ziye, et al.
Publicado: (2022)

Novel insight into the functions of N6-methyladenosine modified lncRNAs in cancers (Review)
por: He, Yingjie, et al.
Publicado: (2022)

Comprehensive Analysis and Prognosis Prediction of N6-Methyladenosine-Related lncRNAs in Immune Microenvironment Infiltration of Gastric Cancer
por: Huang, Jianfeng, et al.
Publicado: (2022)

Novel insights into mutual regulation between N(6)-methyladenosine modification and LncRNAs in tumors
por: Zhang, Nan, et al.
Publicado: (2023)

Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma
por: Weng, Chengyin, et al.
Publicado: (2021)

Construction and Analysis of a Colorectal Cancer Prognostic Model Based on N6-Methyladenosine-Related lncRNAs
por: Zeng, Hanqian, et al.
Publicado: (2021)

N6-Methyladenosine-Related lncRNAs Are Potential Prognostic Biomarkers and Correlated With Tumor Immune Microenvironment in Osteosarcoma
por: Zheng, Di, et al.
Publicado: (2022)

N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma
por: Wu, Zhongguang, et al.
Publicado: (2022)

Cuproptosis- and m6A-Related lncRNAs for Prognosis of Hepatocellular Carcinoma
por: Zhu, Yuezhi, et al.
Publicado: (2023)

Comprehensive analysis of differences of N(6)-methyladenosine of lncRNAs between atrazine-induced and normal Xenopus laevis testis
por: Qi, Xuejie, et al.
Publicado: (2021)

N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer
por: Zhang, He, et al.
Publicado: (2022)

N6-Methyladenosine-Related lncRNAs Are Novel Prognostic Markers and Predict the Immune Landscape in Acute Myeloid Leukemia
por: Zhang, Lulu, et al.
Publicado: (2022)

m6A-related lncRNAs are potential biomarkers for the prognosis of COAD patients
por: Xu, Chenyang, et al.
Publicado: (2022)

Analysis of the role of m6A and lncRNAs in prognosis and immunotherapy of hepatocellular carcinoma
por: Xu, Yan, et al.
Publicado: (2022)

Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer
por: Song, Yang, et al.
Publicado: (2022)

N(6)-Methyladenosine Regulators and Related LncRNAs Are Potential to be Prognostic Markers for Uveal Melanoma and Indicators of Tumor Microenvironment Remodeling
por: Liu, Zhicheng, et al.
Publicado: (2021)

N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients
por: Xu, Shuyu, et al.
Publicado: (2022)

The prognosis biomarkers based on m6A-related lncRNAs for myeloid leukemia patients
por: Yang, Li-Rong, et al.
Publicado: (2022)

N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder Cancer
por: Zhang, Yuying, et al.
Publicado: (2021)

Integrated Analysis of N1-Methyladenosine Methylation Regulators-Related lncRNAs in Hepatocellular Carcinoma
por: Song, Danjun, et al.
Publicado: (2023)

N1-Methyladenosine-Related lncRNAs Are Potential Biomarkers for Predicting Prognosis and Immune Response in Uterine Corpus Endometrial Carcinoma
por: Liu, Jinhui, et al.
Publicado: (2022)

A Prognostic Signature for Colon Adenocarcinoma Patients Based on m6A-Related lncRNAs
por: Zhou, Su-Zhe, et al.
Publicado: (2023)

Identification of N6-Methyladenosine-Related LncRNAs for Predicting Overall Survival and Clustering of a Potentially Novel Molecular Subtype of Breast Cancer
por: Zhong, Xiaoxiao, et al.
Publicado: (2021)

Integrated risk scores from N6-methyladenosine-related lncRNAs are potential biomarkers for predicting the overall survival of bladder cancer patients
por: Huang, Xin, et al.
Publicado: (2022)

m6A-Related lncRNAs Are Potential Biomarkers for the Prognosis of Metastatic Skin Cutaneous Melanoma
por: Huang, Suyang, et al.
Publicado: (2021)

m6A-related lncRNAs predict prognosis and indicate cell cycle in gastric cancer
por: Wan, Dong, et al.
Publicado: (2023)

Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma
por: Han, Chen, et al.
Publicado: (2021)

LncRNAs signatures associated with cuproptosis predict the prognosis of endometrial cancer
por: Qi, Shiyuan, et al.
Publicado: (2023)

Metabolism‐related lncRNAs signature to predict the prognosis of colon adenocarcinoma
por: Sun, Yimin, et al.
Publicado: (2022)

Prognostic Signature of Hepatocellular Carcinoma and Analysis of Immune Infiltration Based on m6A-Related lncRNAs
por: Guo, Ting, et al.
Publicado: (2021)

Identification of m6A‐related lncRNAs as prognostic signature within colon tumor immune microenvironment
por: Cao, Lichao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mjcm0f2hkv8s9lav39jrj54uos